The DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.
Opioid-induced tolerance and dependence in mice is modulated by the distance between pharmacophores in a bivalent ligand series
Open accessAbstract
Given the mounting evidence for involvement of δ opioid receptors in the tolerance and physical dependence of μ opioid receptor agonists, we have investigated the possible physical interaction between μ and δ opioid receptors by using bivalent ligands. Based on reports of suppression of antinociceptive tolerance by the δ antagonist naltrindole (NTI), bivalent ligands [μ-δ agonist-antagonist (MDAN) series] that contain different length spacers, and pharmacophores derived from NTI and the μ agonist oxymorphone, have been synthesized and evaluated by intracerebroventricular (i.c.v.) administration in the tail-flick test in mice. In acute i.c.v. studies, the bivalent ligands functioned as agonists with potencies ranging from 1.6- to 45-fold greater than morphine. In contrast, the monovalent μ agonist analogues were substantially more potent than the MDAN congeners and were essentially equipotent with one another and oxymorphone. Pretreatment with NTI decreased the ED 50 values for MDAN-19 to a greater degree than for MDAN-16 but had no effect on MDAN-21. Chronic i.c.v. studies revealed that MDAN ligands whose spacer was 16 atoms or longer produced less dependence than either morphine or μ monovalent control MA-19. On the other hand, both physical dependence and tolerance were suppressed at MDAN spacer lengths of 19 atoms or greater. These data suggest that physical interaction between the μ and δ opioid receptors modulates μ-mediated tolerance and dependence. Because MDAN-21 was found to be 50-fold more potent than morphine by the i.v. route (i.v.), it offers a previously uncharacterized approach for the development of analgesics devoid of tolerance and dependence.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A METHOD FOR DETERMINING LOSS OF PAIN SENSATION
D'AMOUR, F. E., & SMITH, D. L. (1941) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)03823-6 · Cited by 3,231
PHARMACOLOGICAL EFFECTS PRODUCED BY INTRACEREBRAL INJECTION OF DRUGS IN THE CONSCIOUS MOUSE
HALEY, T. J., & McCORMICK, W. G. (1957) · British Journal of Pharmacology and Chemotherapy · doi:10.1111/j.1476-5381.1957.tb01354.x · Cited by 1,526
Klivenyi, P., Andreassen, O. A., Ferrante, R. J., Dedeoglu, A., Mueller, G., Lancelot, E., Bogdanov, M., Andersen, J. K., Jiang, D., & Beal, M. F. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-01-00001.2000 · Cited by 1,111
SIMULTANEOUS QUANTITATIVE ASSESSMENT OF MORPHINE TOLERANCE AND PHYSICAL DEPENDENCE
WAY, E. L., LOU, H. H., & SHEN, F.-H. (1969) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)28317-3 · Cited by 673
Oligomerization of μ- and δ-Opioid Receptors
George, S. R., Fan, T., Xie, Z., Tse, R., Tam, V., Varghese, G., & O'Dowd, B. F. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m000345200 · Cited by 556
Dimerization of the δ Opioid Receptor:
Cvejic, S., & Devi, L. A. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.43.26959 · Cited by 484
Zhu, Y., King, M. A., Schuller, A. G. P., Nitsche, J. F., Reidl, M., Elde, R. P., Unterwald, E., Pasternak, G. W., & Pintar, J. E. (1999) · Neuron · doi:10.1016/s0896-6273(00)80836-3 · Cited by 430
Abdelhamid, E. E., Sultana, M., Portoghese, P. S., & Takemori, A. E. (1991) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)20227-0 · Cited by 427
Self-citationHeterodimerization of μ and δ Opioid Receptors: A Role in Opiate Synergy
Gomes, I., Jordan, B. A., Gupta, A., Trapaidze, N., Nagy, V., & Devi, L. A. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-22-j0007.2000 · Cited by 403
A role for heterodimerization of μ and δ opiate receptors in enhancing morphine analgesia
Gomes, I., Gupta, A., Filipovska, J., Szeto, H. H., Pintar, J. E., & Devi, L. A. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0307601101 · Cited by 388
A heterodimer-selective agonist shows in vivo relevance of G protein-coupled receptor dimers
Waldhoer, M., Fong, J., Jones, R. M., Lunzer, M. M., Sharma, S. K., Kostenis, E., Portoghese, P. S., & Whistler, J. L. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0501112102 · Cited by 347
Self-citationDesign of peptidomimetic .delta. opioid receptor antagonists using the message-address concept
Portoghese, P. S., Sultana, M., & Takemori, A. E. (1990) · Journal of Medicinal Chemistry · doi:10.1021/jm00168a028 · Cited by 258
Self-citationVaught, J. L., Rothman, R. B., & Westfall, T. C. (1982) · Life Sciences · doi:10.1016/0024-3205(82)90558-6 · Cited by 230
Vaught, J. L., & Takemori, A. E. (1979) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)31528-4 · Cited by 197
Portoghese, P. S. (2001) · Journal of Medicinal Chemistry · doi:10.1021/jm010158+ · Cited by 187
Self-citationFundytus, M. E., Schiller, P. W., Shapiro, M. M., Weltrowska, G., & Coderre, T. J. (1995) · European Journal of Pharmacology · doi:10.1016/0014-2999(95)00554-x · Cited by 162
TAYLOR, D. A. H. B., & Fleming, W. W. (2001) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)29505-7 · Cited by 147
Bhushan, R. G., Sharma, S. K., Xie, Z., Daniels, D. J., & Portoghese, P. S. (2004) · Journal of Medicinal Chemistry · doi:10.1021/jm0342358 · Cited by 135
Self-citationErez, M., Takemori, A. E., & Portoghese, P. S. (1982) · Journal of Medicinal Chemistry · doi:10.1021/jm00349a016 · Cited by 126
Self-citationKest, B., Lee, C. E., McLemore, G. L., & Inturrisi, C. E. (1996) · Brain Research Bulletin · doi:10.1016/0361-9230(95)02092-6 · Cited by 121
Daniels, D. J., Kulkarni, A. A., Xie, Z., et al. (2004) · Journal of Medicinal Chemistry · doi:10.1021/jm034234f · Cited by 117
Self-citationDimeric tetrapeptide enkephalins display extraordinary selectivity for the δ opiate receptor
Shimohigashi, Y., Costa, T., Chen, H., & Rodbard, D. (1982) · Nature · doi:10.1038/297333a0 · Cited by 113
Sánchez‐Blázquez, P., García‐España, A., & Garzón, J. (1997) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)36506-1 · Cited by 97
Involvement of delta 2 opioid receptors in the development of morphine dependence in mice.
Miyamoto, Y., Portoghese, P. S., & Takemori, A. E. (1993) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)10124-9 · Cited by 88
Self-citationAnanthan, S., Kezar, H. S., Carter, R. L., et al. (1999) · Journal of Medicinal Chemistry · doi:10.1021/jm990039i · Cited by 86
Xie, Z., Bhushan, R. G., Daniels, D. J., & Portoghese, P. S. (2005) · Molecular Pharmacology · doi:10.1124/mol.105.012070 · Cited by 85
Self-citationOpioid agonist and antagonist bivalent ligands as receptor probes
Portoghese, P. S., Ronsisvalle, G., Larson, D. L., Yim, C. B., Sayre, L. M., & Takemori, A. E. (1982) · Life Sciences · doi:10.1016/0024-3205(82)90362-9 · Cited by 79
Self-citationSiciński, R. R., Rotkiewicz, P., Koliński, A., Sicińska, W., Prahl, J. M., Smith, C. M., & DeLuca, H. F. (2002) · Journal of Medicinal Chemistry · doi:10.1021/jm020007m · Cited by 69
Aley, K. O., & Levine, J. D. (1997) · Journal of Neuroscience · doi:10.1523/jneurosci.17-20-08018.1997 · Cited by 66
Wells, J., Bartlett, J. L., Ananthan, S., & Bilsky, E. J. (2001) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)29575-6 · Cited by 62
Portoghese, P. S., Larson, D. L., Yim, C. B., et al. (1985) · Journal of Medicinal Chemistry · doi:10.1021/jm00147a002 · Cited by 56
Self-citationHazum, E., Chang, K., Leighton, H. J., Lever, O. W., & Cuatrecasas, P. (1982) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(82)91981-7 · Cited by 52
Portoghese, P. S., Ronsisvalle, G., Larson, D. L., & Takemori, A. E. (1986) · Journal of Medicinal Chemistry · doi:10.1021/jm00159a014 · Cited by 41
Self-citationReceptor binding and biological activity of bivalent enkephalins
Costa, T., Wüster, M., Herz, A., et al. (1985) · Biochemical Pharmacology · doi:10.1016/0006-2952(85)90095-4 · Cited by 37
Dimeric pentapeptide enkephalin: A novel probe of delta opiate receptors
Costa, T., Shimohigashi, Y., Krumins, S. A., Munson, P. J., & Rodbard, D. (1982) · Life Sciences · doi:10.1016/0024-3205(82)90055-8 · Cited by 29
Binding to opioid receptors of enkephalin derivatives taking α‐helical conformation and its dimer
SASAKI‐YAGI, Y., Kimura, S., & Imanishi, Y. (1991) · International journal of peptide & protein research · doi:10.1111/j.1399-3011.1991.tb01517.x · Cited by 9
Cited by
G Protein–Coupled Receptor Oligomerization Revisited: Functional and Pharmacological Perspectives
Ferré, S., Casadó, V., Devi, L. A., Filizola, M., Jockers, R., Lohse, M. J., Milligan, G., Pin, J.-P., & Guitart, X. (2014) · Pharmacological Reviews · doi:10.1124/pr.113.008052 · Cited by 570
Cellular neuroadaptations to chronic opioids: tolerance, withdrawal and addiction
Christie, M. J. (2008) · British Journal of Pharmacology · doi:10.1038/bjp.2008.100 · Cited by 478
Building a new conceptual framework for receptor heteromers
Ferré, S., Baler, R., Bouvier, M., Caron, M. G., Devi, L. A., Durroux, T., Fuxe, K., George, S. R., Javitch, J. A., Lohse, M. J., et al. (2009) · Nature Chemical Biology · doi:10.1038/nchembio0309-131 · Cited by 394
Untangling the complexity of opioid receptor function
Valentino, R. J., & Volkow, N. D. (2018) · Neuropsychopharmacology · doi:10.1038/s41386-018-0225-3 · Cited by 383
Breaking barriers to novel analgesic drug development
Yekkirala, A. S., Roberson, D. P., Bean, B. P., & Woolf, C. J. (2017) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2017.87 · Cited by 364
Metadata
- Authors
- Daniels, D. J., Lenard, N. R., Etienne, C. L., Law, P.-Y., Roerig, S. C., & Portoghese, P. S.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 2005-12-19
- Volume
- 102
- Issue
- 52
- Pages
- 19208-19213
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2054982830
- Cited by
- 297
- References
- 36
- FWCI
- 4.42
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.